10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 150 filers reported holding 10X GENOMICS INC in Q2 2020. The put-call ratio across all filers is 0.31 and the average weighting 2.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,196,156 | +18.9% | 101,725 | +61.0% | 0.10% | +14.1% |
| Q2 2023 | $3,528,362 | +44.8% | 63,187 | +44.6% | 0.09% | +37.3% |
| Q1 2023 | $2,437,242 | -63.8% | 43,686 | -76.3% | 0.07% | -64.9% |
| Q4 2022 | $6,726,241 | +229.2% | 184,584 | +157.3% | 0.19% | +165.3% |
| Q3 2022 | $2,043,000 | +440.5% | 71,750 | +758.3% | 0.07% | +323.5% |
| Q2 2022 | $378,000 | -73.9% | 8,360 | -56.2% | 0.02% | -75.0% |
| Q1 2022 | $1,451,000 | -48.6% | 19,077 | +0.7% | 0.07% | -60.9% |
| Q4 2021 | $2,822,000 | +583.3% | 18,942 | +799.0% | 0.17% | +397.1% |
| Q2 2021 | $413,000 | -87.2% | 2,107 | -90.7% | 0.04% | -89.7% |
| Q4 2020 | $3,218,000 | +148.9% | 22,729 | +119.2% | 0.34% | +310.8% |
| Q3 2020 | $1,293,000 | +167.7% | 10,370 | +91.9% | 0.08% | +144.1% |
| Q2 2020 | $483,000 | – | 5,405 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,358,528 | $49,504,760 | 100.00% |
| Meritech Capital Associates V L.L.C. | 1,061,682 | $38,687,692 | 9.44% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $13,102,148 | 4.90% |
| Sands Capital Ventures, LLC | 481,770 | $17,556 | 4.81% |
| Whitford Management LLC | 58,310 | $2,124,803 | 2.88% |
| FINANCIAL CONSULATE, INC | 156,457 | $5,701,293 | 1.99% |
| SRS Investment Management, LLC | 3,005,427 | $109,517,760 | 1.98% |
| BRANDYWINE MANAGERS, LLC | 11,208 | $408,420 | 1.43% |
| ARK Investment Management | 4,316,567 | $157,295,701 | 1.36% |
| Nikko Asset Management Americas, Inc. | 2,177,988 | $79,365,883 | 1.14% |